# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-043589
Filing Date
2024-11-05
Accepted
2024-11-05 06:21:44
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | forms-1a.htm | S-1/A | 559920
2 |  | ex23-1.htm | EX-23.1 | 4041
3 |  | forms-1_001.jpg | GRAPHIC | 75413
4 |  | forms-1_002.jpg | GRAPHIC | 700964
5 |  | forms-1_003.jpg | GRAPHIC | 142431
6 |  | forms-1_004.jpg | GRAPHIC | 393138
| Complete submission text file | 0001493152-24-043589.txt |  | 2370290

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-282781 | Film No.: 241425494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)